EMFAT
Emerald Mutual Fund Advisers Trust’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-176,675
| Closed | -$6.82M | – | 258 |
|
|
2022
Q4 | $6.82M | Sell |
176,675
-226,439
| -56% | -$8.74M | 0.42% | 89 |
|
|
2022
Q3 | $21.4M | Buy |
403,114
+100,636
| +33% | +$5.35M | 1.36% | 15 |
|
|
2022
Q2 | $17.6M | Buy |
302,478
+49,651
| +20% | +$2.89M | 1.02% | 31 |
|
|
2022
Q1 | $19.3M | Buy |
+252,827
| New | +$19.3M | 0.85% | 44 |
|